Alcon Inc. ALC recently announced the availability of Clareon Vivity — the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) on Alcon’s most advanced lens platform ...
Key findings from across the 21 scientific presentations on Alcon products will be presented at the meeting, including the soon-to-launch, first non-diffractive extended depth of focus AcrySof® IQ ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...
FORT WORTH, Texas--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people See Brilliantly, will present a breadth of data during the ...
Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating an investigational accommodating intraocular lens (IOL) developed by ...
Please provide your email address to receive an email when new articles are posted on . Advances in toric IOL technology and the option to correct presbyopia and astigmatism with the same lens have ...
A cataract is the opacification of the eye's natural lens, usually causing gradual eyesight deterioration and potentially leading to blindness. Current treatment involves replacing the opacified lens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results